(Q51436106)

5 April 2018

title

Selective vasodilation by nitric oxide inhalation during sustained pulmonary hypertension following recurrent microembolism in pigs. (English)

1 reference

5 April 2018

author name string

Weimann J

1

1 reference

5 April 2018

Zink W

2

1 reference

5 April 2018

Schnabel PA

3

1 reference

5 April 2018

Jakob H

4

1 reference

5 April 2018

Gebhard MM

5

1 reference

5 April 2018

Martin E

6

1 reference

5 April 2018

Motsch J

7

1 reference

5 April 2018

publication date

1 September 1999

1 reference

5 April 2018

published in

Journal of Critical Care

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

133-140

1 reference

5 April 2018

Time course of pulmonary vascular response to microembolization

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Hypoxemia in acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Thrombolysis for pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Chronic major-vessel thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Fulminant pulmonary embolism: symptoms, diagnostics, operative technique, and results

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Heart-lung transplantation: lessons learned and future hopes

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Vasodilator therapy in microembolic porcine pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

The treatment of pulmonary heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

A model of embolic chronic pulmonary hypertension in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Reduction in nitrogen dioxide concentration by soda lime preparations during simulated nitric oxide inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goats.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Pulmonary vascular pressure-flow characteristics in canine pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Site of pulmonary vasodilation by inhaled nitric oxide in microembolic lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Pulmonary hemodynamics and blood flow characteristics in chronic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Hemodynamics in dogs with pulmonary hypertension due to emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Use of inhaled nitric oxide to reverse flow through a patent foramen ovale during pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide in patients with pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990026-6

7 January 2021

10.1016/S0883-9441(99)90026-6

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018